Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 6
2005 6
2006 4
2007 5
2008 6
2009 4
2010 7
2011 7
2012 7
2013 9
2014 7
2015 13
2016 8
2017 16
2018 17
2019 11
2020 22
2021 28
2022 18
2023 14
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

193 results

Results by year

Filters applied: . Clear all
Page 1
Multiple switching between the biosimilar adalimumab PF-06410293 and reference adalimumab in patients with active rheumatoid arthritis: a phase 3, open-label, randomised, parallel-group study.
Fleischmann RM, Saikali W, Lakhanpal S, Alvarez DF, Cox DS, Ianos CA, Zhang W, Cronenberger C, Wang K. Fleischmann RM, et al. Among authors: alvarez df. Lancet Rheumatol. 2023 Sep;5(9):e532-e541. doi: 10.1016/S2665-9913(23)00161-3. Epub 2023 Aug 21. Lancet Rheumatol. 2023. PMID: 38251497 Clinical Trial.
A deep learning model based on the combination of convolutional and recurrent neural networks to enhance pulse oximetry ability to classify sleep stages in children with sleep apnea.
Vaquerizo-Villar F, Alvarez D, Gutierrez-Tobal GC, Del Campo F, Gozal D, Kheirandish-Gozal L, Penzel T, Hornero R. Vaquerizo-Villar F, et al. Among authors: alvarez d. Annu Int Conf IEEE Eng Med Biol Soc. 2023 Jul;2023:1-4. doi: 10.1109/EMBC40787.2023.10341100. Annu Int Conf IEEE Eng Med Biol Soc. 2023. PMID: 38082822
"Long-term oncologic outcomes and risk factors for distant recurrence after pathologic complete response following neoadjuvant treatment for locally advanced rectal cancer. A nationwide, multicentre study".
Cerdán-Santacruz C, Cano-Valderrama Ó, Santos Rancaño R, Terés LB, Vigorita V, Pérez TP, Rosciano Paganelli JG, Paredes Cotoré JP, Carre MK, Flor-Lorente B; Collaborating group for the study of long-term oncologic results of pathologic complete response in locally advanced rectal cancer patients; Spanish Rectal Cancer Project (Vikingo); Antona FB, Martín EY, Tebar JC, Cao IA, Coltell ZB, Alonso MG, Paredes Cotoré JP, Prada López BL, Riesco AB, Cánovas NI, Sánchez CM, Serrat DR, Conde GA, Toscano MJ, Aira AC, Pérez MR, Petit NM, Espín Basany E, Carré MK, Pellino G, Retuerta JM, Saldaña AG, Laso CÁ, Allende IA, Álvarez DH, Cazador AC, Sánchez Bautista WM, Torres Sánchez MT, Bonito AC, Velázquez MC, Díaz OM, Fuentes NS, Olías MDCV, Pérez TP, Rosciano Paganelli JG, Lorente BF, Valderrama ÓC, Santos Rancaño R, Terés LB, Santacruz CC. Cerdán-Santacruz C, et al. Among authors: alvarez dh. Eur J Surg Oncol. 2023 Oct;49(10):106962. doi: 10.1016/j.ejso.2023.06.014. Epub 2023 Jun 29. Eur J Surg Oncol. 2023. PMID: 37414628
193 results